However, certain circumstances may warrant testing including pre-existing liver or kidney conditions where monitoring organ function during therapy provides appropriate oversight, specific health concerns that might benefit from objective biomarker assessment, desire to objectively measure oxidative stress markers or glutathione status before and during therapy, and medical conditions requiring monitoring for safety reasons
-
Schad ML, McMillan GP, Thielman EJ, Groon K, Morse-Fortier C, Martin JL, Henry JA
If you prefer, our pharmacy will contact your doctor's office to request a new prescription directly
Food and Drug Administration, 2026)
The patient would start on the starter dose of 0.25mg if approved for Wegovy